13 employees
Prestige Biologics is a CDMO that provides development and manufacturing solutions for clinical biopharmaceuticals from idea to production.
2018
$59M
from 1 investors over 1 rounds
Prestige Biologics Ltd. raised $59M on March 15, 2022
Investors: La octava.